The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2020

Filed:

Apr. 07, 2017
Applicant:

Shanghai Biomed-union Biotechnology Co., Ltd, Pudong New District, Shanghai, CN;

Inventors:

Xilian Yue, Shanghai, CN;

Gentao Liu, Shanghai, CN;

Guoxiang Wu, Shanghai, CN;

Assignee:

Shanghai Biomed-Union Biotechnology Co., Ltd., Pudong New District, Shanghai, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 14/55 (2006.01); A61K 39/395 (2006.01); A61K 38/20 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2818 (2013.01); C07K 14/55 (2013.01); A61K 2039/505 (2013.01); C07K 2319/33 (2013.01);
Abstract

A fusion protein for restoring functions of failing immune cells and application thereof. The fusion protein has a functional area for recognizing the failing immune cell and a functional area for conducting activation and amplification on the failing immune cell. The two functional areas are connected through a non-functional amino acid fragment with a certain length. The functional area for recognition uses the immune checkpoint specific antibody to recognize a phenotypic receptor of failing immune cells. The functional area for conducting activation and amplification adopts the cytokine or functionally-similar mutants, a ligand of the phenotypic receptor or functionally-similar mutants or an activating antibody to activate failing immune cells. The fusion protein recognizes failing immune cells, conducts activation and amplification on recognized failing immune cells, restores functions of killing antigen positive cells by the immune cells, and enhances inhibition of tumor growth and virus infection control.


Find Patent Forward Citations

Loading…